Localization of rose bengal, aluminum phthalocyanine tetrasulfonate, and chlorin E 6 in the rabbit eye

Retina

Volumn 22, Issue 1, 2002, Pages 65-74

  Haimovici, Robert ^a,c,d   Ciulla, Thomas A ^a   Miller, Joan W ^a   Hasan, Tayyaba ^b   Flotte, Thomas J ^b   Kenney, Alice G ^a   Schomacker, Kevin T ^b   Gragoudas, Evangelos S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Gundersen Eye Center   (United States)

Author keywords

Aluminum phthalocyanine tetrasulfonate; Angiography; Chlorin e 6; Choroid; Eye; Photodynamic therapy; Photosensitizer; Rabbit; Retina; Rose bengal

Indexed keywords

ROSE BENGAL; TALAPORFIN; TETRASULFOPHTHALOCYANINE ALUMINUM; CHLORIN E6; INDOLE DERIVATIVE; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT; PORPHYRIN;

ARTICLE; CHOROID; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG ACCUMULATION; DRUG DISTRIBUTION; ENUCLEATION; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FLUORESCENCE MICROSCOPY; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; RABBIT; ANIMAL; COMPARATIVE STUDY; EYE; METABOLISM; TISSUE DISTRIBUTION;

ANIMALS; EYE; FLUORESCEIN ANGIOGRAPHY; INDOLES; MICROSCOPY, FLUORESCENCE; ORGANOMETALLIC COMPOUNDS; PHOTOSENSITIZING AGENTS; PORPHYRINS; RABBITS; ROSE BENGAL; TISSUE DISTRIBUTION;

EID: 0036482780     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200202000-00012     Document Type: Article

References (49)

1. Thomas E, Langhoffer M. Closure of experimental subretinal neovascular vessels with dihematopophyrin ether augmented argon green laser photocoagulation. Photochem Photobiol 1987;46:881-886.
2. Kramer M, Miller J, Michaud N, et al. Photodynamic therapy (PDT) of experimental choroidal neovascularization (CNV) using liposomal benzoporphyrin derivative monoacid (BPD-MA): refinement of dosimetry. Ophthalmology 1996;103:427-438.
3. Miller H, Miller B. Photodynamic therapy of subretinal neovascularization in the monkey eye. Arch Ophthalmol 1993;111:855-860.
4. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-560.
5. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol 2001;119:198-207.
6. Haimovici R, Kramer M, Flotte T, Miller J, Gragoudas E. Localization of benzoporphyrin derivative in the rabbit eye. Curr Eye Res 1997;16:83-90.
7. Kim RY, Hu LK, Flotte TJ, et al. Digital angiography of experimental choroidal melanomas using benzoporphyrin derivative. Am J Ophthalmol 1997;123:810-816.
8. Gomer C, Jester J, Razum N, Szirth B, Murphree A. Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long term damage in rabbit ocular tissue. Cancer Res 1985;45:3718-3725.
9. Hill RA, Esterowitz T, Ryan J, et al. Photodynamic laser cyclodestruction with chloraluminum sulfonated phthalocyanine (CASPc) or Photofrin (PII) vs. Nd:YAG laser cyclodestruction in a pigmented rabbit model. Lasers Surg Med 1995;17:166-171.
10. Hill RA, Garret J, Reddi S, et al. Photodynamic therapy of the ciliary body with silicon naphthalocyanine (SINc) in rabbits. Lasers Surg Med 1996;18:86-91.
11. Hill RA, Crean DH, Doiron DR, et al. Photodynamic therapy of the ciliary body with tin ethyl etiopurpurin and octaethyl benzochlorin in pigmented rabbits. Ophthalmic Surg Lasers 1997;28:948-953.
12. Kliman GH, Puliafito CA, Stern D, et al. Phthalocyanine photodynamic therapy: new strategies for closure of choroidal neovascularization. Lasers Surg Med 1994;15:2-10.
13. Moshfeghi D, Peyman GA, Kazi AA, et al. Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys. Ophthalmic Surg Lasers 1999;30:750-753.
14. Hikichi T, Mori F, Nakajima S, et al. Dynamic observation of selective accumulation of a photosensitizer and its photodynamic effects in rat experimental choroidal neovascularization. Retina 2001;21:126-131.
15. Blumenkranz MS, Woodburn KW, Qing F, et al. Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy. Am J Ophthalmol 2000;129:353-362.
16. Gonzalez VH, Hu LK, Theodossiadis PG, et al. Photodynamic therapy of pigmented choroidal melanomas. Invest Ophthalmol Vis Sci 1995;36:871-878.
17. 6 in the photodynamic therapy of malignant tumors. Am J Ophthalmol 2000;129:353-362.
18. Linden S, Neckers D. Type I and type II sensitizers based on rose bengal onium salts. Photochem Photobiol 1988;47:543-550.
19. Gandin E, Lion Y, Van de Vorst A. Quantum yield of singlet oxygen production by xanthene derivatives. Photochem Photobiol 1983;37:271-278.
20. Gottfried C, Peled D, Winkelman J, Kimel S. Photosensitizers in organized media: singlet oxygen production and spectral properties. Photochem Photobiol 1088;48:157-163.
21. Spikes J. Chlorins as photosensitizers in biology and medicine. J Photochem Photobiol B 1990;6:259-274.
22. Kreimer-Birnbaum M. Modified porphyrins, chlorins, phthalocyanines and purpurins: second generation photosensitizers for photodynamic therapy. Semin Hematol 1989;26:157-173.
23. Moan J, Peng Q, Evensen J, Berg K, Western A, Riminton C. Photosensitizing efficiencies, tumor and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol 1987;46:713-721.
24. Schmidt U, Birngruber R, Hasan T. Selective occlusion of ocular neovascularization using photodynamic therapy. Ophthalmology 1992;89:391-394.
25. Melamed S, Ben-Sira I, Sen-Shaul Y. Ultrastructure of fenestrations in endothelial choriocapillaris of the rabbit. Br J Ophthalmol 1980;64:537-543.
26. Tornquist P, Alm A, Bill A. Permeability of ocular vessels and transport across the blood-retinal barrier. Eye 1990;4:303-309.
27. Bill A. Capillary permeability to and extravascular dynamics of myoglobin, albumin, and gamma globulin in the uvea. Acta Physiol Scand 1968;73:204-219.
28. Rapoport S. Osmotic opening of the blood-brain and blood-ocular barriers. Exp Eye Res 1977;25(suppl):499-509.
29. Netto M, Martins-Ferreira H. Elicitation of spreading depression by rose bengal photodynamic therapy. Photochem Photobiol 1989;50:229-234.
30. Menon I, Basu P, Persad S, Rosatone S, Wiltshire J. A study on the sequence of phototoxic effects of rose bengal using retinal pigment epithelial cells in vitro. Exp Eye Res 1989;49:67-73.
31. Büchi E, Lam T, Suvaizdis I, Tso M. Injuries induced by diffuse photodynamic action in retina and choroid of albino rats. Retina 1994;14:370-378.
32. Royster A, Nanada S, Hatchell D, Tiedman D, Dutton J. Photochemical initiation of thrombosis. Arch Ophthalmol 1988;106:1608-1614.
33. Yao X-Y, Marmor M. Induction of serous retinal detachment in rabbit eyes by pigment epithelial and choriocapillary injury. Arch Ophthalmol 1992;110:541-546.
34. Mosinger J, Olney J. Photothrombosis-induced ischemic neuronal degeneration in the rat retina. Exp Neurol 1989;105:110-113.
35. Wilson C, Royster A, Tiedman J, Hatchell D. Exudative retinal detachment after photodynamic injury. Arch Ophthalmol 1991;109:125-134.
36. Wilson C, Hatchell D. Photodynamic retinal vascular thrombosis. Invest Ophthalmol Vis Sci 1991;32:2357-2365.
37. Nanda S, Hatchell D, Tiedman J, Dutton J, Hatchell M, McAdoo T. A new method for vascular occlusion. Arch Ophthalmol 1987;105:1121-1124.
38. Lewis M, Winward K, Watson B, Hernandez E. Photochemical thrombosis of retinal and choroidal vessels using rose bengal. Spieg Hist 1989;1066:29-32.
39. Marmor M, Yao X-Y. Conditions necessary for the formation of serous detachment. Arch Ophthalmol 1994;112:830-838.
40. Mori K, Yoneya S, Ohta M, et al. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6). Ophthalmology 1999;106:1384-1391.
41. Kliman GH, Puliafito CA, Grossman GA, et al. Retinal and choroidal vessel closure using phthalocyanine photodynamic therapy. Lasers Surg Med 1994;15:11-18.
42. Reinke MH, Canakis C, Husain D. Verteporfin photodynamic therapy retreatments of normal retina and choroid in the cynomolgus monkey. Ophthalmology 1999;106:1915-1923.
43. Peyman GA, Kazi AA, Unal M, et al. Problems with and pitfalls of photodynamic therapy. Ophthalmology 2000;107:29-35.
44. Moor ACE. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B 2000;57:1-13.
45. Shuler MF, Borrillo JL, HO AC. Photodynamic therapy update. Curr Opin Ophthalmol 2001;12:202-206.
46. Paczkowski J, Lamberts J, Paczkowski B, Neckers D. Photophysical properties of rose bengal and its derivatives (XII). J Free Radic Biol Med 1985;1:341-351.
47. Tralau C, MacRobert A, Coleridge-Smith P, Barr H, Brown S. Photodynamic therapy with phthalocyanine sensitization: quantitative studies in a transplantable rat fibrosarcoma. Br J Cancer 1987;55:389-395.
48. Sollom A. Ocular tissue staining in the rabbit after fluorescein injection. Exp Eye Res 1968;7:551-555.
49. Fang T, Naguib K, Peyman G, Khoobehi B. Comparative study of three fluorescent dyes for angiography: sodium fluorescein, carboxyfluorescein, and calcein. Ophthalmic Surg 1990;21:250-257.